Holen Sie sich die Stockscreener-App
67.34
1.29%
-0.88
Handel nachbörslich:
67.34
Schlusskurs vom Vortag:
$68.22
Offen:
$68.22
24-Stunden-Volumen:
1.08M
Relative Volume:
0.58
Marktkapitalisierung:
$14.98B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
27.94
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
+0.28%
1M Leistung:
+0.87%
6M Leistung:
+10.65%
1J Leistung:
-16.08%
1-Tages-Spanne:
$66.94
$68.22
1-Wochen-Bereich:
$66.32
$69.13
52-Wochen-Spanne:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
67.34 | 15.17B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
449.69 | 162.16B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
191.99 | 55.49B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
281.38 | 40.66B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.82 | 38.26B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
268.07 | 19.60B | 2.96B | 487.70M | 344.00M | 6.68 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
What to do if you’re stuck in Hologic Inc.Earnings Overview Summary & AI Powered Market Entry Ideas - newser.com
How Hologic Inc. (HO1) stock reacts to monetary easingEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
How to Play HOLX Stock This Breast Cancer Awareness Month? - Yahoo
Technical analysis overview for Hologic Inc. stock2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Will Dual FDA and CE Approvals for Panther Fusion Shape Hologic's (HOLX) Long-Term Story? - simplywall.st
What dividend safety rating applies to Hologic Inc. (HO1) stockWeekly Trend Summary & Weekly Top Gainers Alerts - newser.com
Should I buy Hologic Inc. (HO1) stock before earnings seasonPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Greenleaf Trust Purchases 173 Shares of Hologic, Inc. $HOLX - Defense World
Chart based analysis of Hologic Inc. trendsTake Profit & Fast Momentum Entry Tips - newser.com
Is Hologic Inc. stock a buy before product launchesPortfolio Performance Report & Entry Point Confirmation Signals - newser.com
Key metrics from Hologic Inc.’s quarterly dataJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests - Yahoo
Risk adjusted return profile for Hologic Inc. analyzed2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Farther Finance Advisors LLC Increases Stock Position in Hologic, Inc. $HOLX - Defense World
User - FinancialContent
Is Hologic Inc. stock trading near support levelsEntry Point & High Return Trade Guides - newser.com
Why Hologic (HOLX) Outpaced the Stock Market Today - sharewise.com
Hologic Panther Fusion GI Assays - Infectious Disease Special Edition
Press Release: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025 - 富途牛牛
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025 - The Globe and Mail
Hologic (HOLX): Assessing Valuation Following Upbeat Earnings, Guidance Boost, and New Partnership Moves - Yahoo Finance
Hologic gains FDA clearance for GI pathogen detection assays - Medical Device Network
New Data on AI-Powered Mammography Technology Presented at European Breast Imaging Meeting - Imaging Technology News
Hologic Earns FDA, EU Nods for Infectious Gastroenteritis Tests - Medical Product Outsourcing
FDA Clears Hologic's (HOLX) New Diagnostic Assays - GuruFocus
Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious GastroenteritisHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum - The Globe and Mail
Park Avenue Securities LLC Sells 2,368 Shares of Hologic, Inc. $HOLX - Defense World
Hologic jumps after report Blackstone, TPG have revived takeover interest - MSN
Minicarm.com to distribute Hologic’s Fluoroscan Insight FD mini C-arm in U.S. - DOTmed
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term - sharewise.com
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
New Survey Results Underscore the Need to #BustTheMyth About MammogramsHologic, Inc. - Hologic, Inc. - Investor Relations
MA-HOLOGIC-INC - The Facts
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):